Document is current
Any future updates will be listed below
-
Authors
De, Suman
Whiten, Daniel R.
Ruggeri, Francesco S.
Hughes, Craig
Rodrigues, Margarida
Sideris, Dimitrios I.
Taylor, Christopher G.
Aprile, Francesco A.
Muyldermans, Serge
Knowles, Tuomas P. J.
Vendruscolo, Michele
Bryant, Clare
Blennow, Kaj
Skoog, Ingmar
Kern, Silke
Zetterberg, Henrik
Klenerman, David http://orcid.org/0000-0001-7116-6954
-
Funding
Funding for this research was provided by:
European Research Council (669237, 681712)
Vetenskapsrådet (2015-02830, 2013-8717)
- License Information
-
More Information
Article History
Received: 16 July 2019
Accepted: 18 July 2019
First Online: 26 July 2019
Competing interests
: CEB is a member of the GSK Immunology Catalyst, serves on the scientific advisory board of Nodthera, is a consultant for Syncona and a co-founder of Polypharmakos. KB has served as a consultant or at advisory boards for Alector, Alzheon, CogRx, Biogen, Lilly, Novartis and Roche Diagnostics, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg, IS has served as a consultant for Takeda. HZ has served at scientific advisory boards for Roche Diagnostics, Wave, Samumed and CogRx and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg, all unrelated to the work presented in this paper. All the other authors declare no competing interests.
